Provider
P58-23 Medicare Advantage Part B Step Therapy Program Expansion to Include Vyvgart and Ultomiris
Program effective Date: Aug 01, 2023
Search Results
Displaying 2101 - 2110 of 3878 results
Provider
2023 August Bulletins
Program effective Date: Aug 01, 2023
Provider
QP65-23 New Medical Coding Pattern Education Program
Program effective Date: Jul 26, 2023
Provider
QP60-23 Commercial Pharmacy Benefit Exclusion for Elfabrio®, Vyjuvek™
Program effective Date: Jul 12, 2023
Provider
QP61-23 MHCP Pharmacy Benefit Exclusion for Elfabrio®, Epkinly™, and Vyjuvek™
Program effective Date: Jul 12, 2023
Provider
QP62-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023
Program effective Date: Jul 12, 2023
Provider
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Program effective Date: Jul 12, 2023
Provider
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox)
Program effective Date: Jul 12, 2023
Financial Information
Provider
commercial-em-007-critical-care-services.pdf